Loading...
XTAI
1731
Market cap96mUSD
Aug 01, Last price  
21.65TWD
1D
0.00%
1Q
-2.48%
Jan 2017
58.03%
IPO
128.39%
Name

Maywufa Co Ltd

Chart & Performance

D1W1MN
P/E
16.61
P/S
1.94
EPS
1.30
Div Yield, %
5.31%
Shrs. gr., 5y
-0.28%
Rev. gr., 5y
6.18%
Revenues
1.49b
+14.23%
2,858,709,0003,009,097,0002,247,147,0002,146,907,0001,512,329,0001,232,868,0001,369,188,0001,443,068,0001,575,078,0001,123,398,0001,100,863,0001,065,325,0001,289,211,0001,245,105,0001,300,721,0001,485,873,000
Net income
173m
+2.44%
57,629,00058,107,00042,090,00059,721,00063,573,00080,524,00079,086,00090,733,00085,937,00075,765,000100,605,000171,002,000164,321,000161,830,000169,098,000173,232,000
CFO
216m
-11.72%
-12,393,00091,476,00051,699,000269,007,000122,416,000203,800,000155,604,00067,022,000225,630,000228,458,000217,457,000240,462,000262,975,000147,884,000244,319,000215,695,000
Dividend
Jun 28, 20241.15 TWD/sh

Profile

Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It offers hair care products; health care products and food supplements; and mother and baby skin care products under the mustela brand. The company also provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. In addition, it sells and distributes pharmaceutical products; and operates and manages pharmacy chain under the Pharmacy Franchise name. Maywufa Company Ltd. was founded in 1976 and is headquartered in Taipei, Taiwan.
URL
https://www.maywufa.com.tw/
IPO date
Sep 17, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,485,873
14.23%
1,300,721
4.47%
1,245,105
-3.42%
Cost of revenue
1,278,201
1,105,374
1,046,598
Unusual Expense (Income)
NOPBT
207,672
195,347
198,507
NOPBT Margin
13.98%
15.02%
15.94%
Operating Taxes
44,823
41,150
46,523
Tax Rate
21.58%
21.07%
23.44%
NOPAT
162,849
154,197
151,984
Net income
173,232
2.44%
169,098
4.49%
161,830
-1.52%
Dividends
(152,853)
(146,207)
(155,511)
Dividend yield
5.08%
4.89%
5.92%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
36,828
3,689
8,418
Long-term debt
641,290
443,625
227,151
Deferred revenue
Other long-term liabilities
1,945
1,945
1,893
Net debt
(145,823)
(760,963)
(569,174)
Cash flow
Cash from operating activities
215,695
244,319
147,884
CAPEX
(269,419)
(251,559)
(230,393)
Cash from investing activities
(283,933)
(308,390)
36,198
Cash from financing activities
62,350
66,518
(245,539)
FCF
(128,708)
(100,428)
(88,801)
Balance
Cash
605,487
573,611
584,378
Long term investments
218,454
634,666
220,365
Excess cash
749,647
1,143,241
742,488
Stockholders' equity
1,672,531
1,847,836
1,808,951
Invested Capital
2,032,913
1,338,526
1,463,135
ROIC
9.66%
11.01%
10.60%
ROCE
7.46%
7.87%
9.00%
EV
Common stock shares outstanding
131,437
133,267
132,915
Price
22.90
2.00%
22.45
13.67%
19.75
1.02%
Market cap
3,009,900
0.60%
2,991,844
13.97%
2,625,071
0.72%
EV
2,864,077
2,230,881
2,055,897
EBITDA
245,093
224,142
227,788
EV/EBITDA
11.69
9.95
9.03
Interest
3,170
92
2,561
Interest/NOPBT
1.53%
0.05%
1.29%